Browsing by Author Central Clinical School: The Sydney Cancer Centre

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 124  next >
Issue DateTitleAuthor(s)Citation
201318F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanomaCarlino, Matteo; Haydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Saunders, Catherine; Curtis, C. Martin; Lebowitz, Peter; Menzies, Alexander; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine18F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma, European Journal of Cancer, vol.49, 2, 2013,pp 395-402
2008Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancerBoyer, Michael; Clifford, A.R.; Fulham, Michael; Gao, K; Hughes, Ceri; Jackson, Michael; Martin, Richard; Milross, Christopher; O'Brien, Christopher; Shannon, Kerwin; Tin, Mo Mo; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Melanoma Foundation; Central Clinical School: Medicine; Central Clinical School: Surgery; Medicine; Central Clinical School: MedicineAccuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer, Head and Neck, vol.31, 2, 2008,pp 244-250
2014Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinibAnforth, Rachael; Clements, Arthur; Fernandez Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Nguyen, Bao; Liu, Michael; Uribe, Pablo; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Nepean Clinical School: MedicineAcneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib, The Australasian Journal of Dermatology, vol.55, 4, 2014,pp 250-254
2015Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Pupo, Gulietta; Rizos, Helen; Scolyer, Richard; Thompson, John; Becker, Jurgen C; Berking, Carola; Eroglu, Zeynep; et al, Various; Gogas, Helen; Gutzmer, R.; Johnson, Douglas B; Sucker, Antje; Ye, Fei; Zhao, Shilin; Zimmer, Lisa; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: Pathology; Central Clinical School: SurgeryAcquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms, European Journal of Cancer, vol.51, 18, 2015,pp 2792-2799
2014Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor TherapyKefford, Richard (Rick); Long, Georgina; Chodon, Thinle; Dahlman, Kimberly; et al, Various; Guo, Rongqing; Hong, Aayoung; Hugo, Willy; Johnson, Douglas B; Kong, Xiangju; Koya, Richard; Moriceau, Gatien; Shi, Hubing; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreAcquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy, Cancer Discovery, vol.4, 1, 2014,pp 80-93
2014Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanomaLong, Georgina; Bowyer, Samantha; Hicks, Rodney J; Lyle, Megan; McArthur, Grant A.; Millward, Michael; Raleigh, Jeanette; Rao, Aparna; Sandhu, Shahneen; Central Clinical School: The Sydney Cancer CentreActivity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma, Melanoma Research, vol.24, 5, 2014,pp 504-508
2013Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition Following Acquired Resistance to BRAF and/or MEK Inhibition in MelanomaBecker, Therese; Carlino, Matteo; Gowrishankar, Kavitha; Kefford, Richard (Rick); Long, Georgina; Pupo, Gulietta; Rizos, Helen; Saw, Robyn; Snoyman, Stephanie; Saunders, Catherine; Zhang, Xu Dong; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Surgery; Western Clinical School: Westmead Millennium InstituteAntiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition Following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma, Molecular Cancer Therapeutics, vol.12, 7, 2013,pp 1332-1342
2017Assessment of voluntary deep inspiration breath-hold with CINE imaging for breast radiotherapyCarroll, Susan; Naehrig, Diana; Toohey, J; Attwood, Lani; Claridge-Mackonis, Elizabeth; Estoesta, Reuben Patrick; Martin, Darren; Odgers, David; Pham, Melissa; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: ImagingAssessment of voluntary deep inspiration breath-hold with CINE imaging for breast radiotherapy, Journal of Medical Imaging and Radiation Oncology, vol.61, 5, 2017,pp 689-694
2012Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF InhibitionLong, Georgina; Busam, Klaus; Carvajal, Richard; Dummer, R; Egberts, Friederike; Goldinger, Simone; Hauschild, A; Hillen, Uwe; Kashani-Sabet, Mohammed; Lacouture, Mario; Livingstone, Elisabeth; McArthur, Grant A.; Schadendorf, Dirk; Scherag, Andre; Sucker, Antje; Zimmer, Lisa; Central Clinical School: The Sydney Cancer CentreAtypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition, Journal of Clinical Oncology, vol.30, 19, 2012,pp 2375-2383
2015Blockade of MMP14 activity in murine breast carcinomas: Implications for macrophages, vessels, and radiotherapyGoel, Shom; Ager, Eleanor; Askoxylakis, Vasileios; et al, Various; Finkelstein, Dianne; Huang, Yuhui; Kirkpatrick, Nathaniel; Kodack, David; Kozin, Sergey; Muzikansky, Alona; Seano, Giorgio; Snuderl, Matija; Central Clinical School: The Sydney Cancer CentreBlockade of MMP14 activity in murine breast carcinomas: Implications for macrophages, vessels, and radiotherapy, Journal of the National Cancer Institute, vol.107, 4, 2015,pp 1-12
2015BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell VolumeLong, Georgina; Scolyer, Richard; Bosenberg, Marcus; Held, Matthew; Marzuka-Alcala, Alexander; Meeth, Katrina M; Micevic, Goran; Stern, David F; Theodosakis, Nicholas; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyBRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume, Molecular Cancer Therapeutics, vol.14, 7, 2015,pp 1680-1692
2013BRAF inhibitor activity in V600R metastatic melanomaClements, Arthur; Kefford, Richard (Rick); Long, Georgina; O'Toole, Sandra; Klein, Oliver; Menzies, Alexander; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyBRAF inhibitor activity in V600R metastatic melanoma, European Journal of Cancer, vol.49, 5, 2013,pp 1073-1079
2014BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impactBecker, Therese; Boyd, Suzanah; Carlino, Matteo; Fung, Carina; Haydu, Lauren; Howle, Julie; Kefford, Richard (Rick); Long, Georgina; Mijatov, Branka; Pupo, Gulietta; Rizos, Helen; Saw, Robyn; Scolyer, Richard; Thompson, John; Hyman, Jessica; Menzies, Alexander; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Infectious Diseases; Central Clinical School: Surgery; Western Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: SurgeryBRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact, Clinical Cancer Research, vol.20, 7, 2014,pp 1965-1977
2016BRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reportingCooper, Wendy Anne; Kakavand, Hojabr; Long, Georgina; O'Toole, Sandra; Saw, Robyn; Scolyer, Richard; Smith, Elisabeth; Walker, Emily; Wilmott, James; Yu, Bing; Lum, Trina; Selinger, Christina; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: Surgery; Central Clinical School: MedicineBRAF(V600E) and NRAS(Q61L/Q61R) mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting, Histopathology, vol.69, 4, 2016,pp 680-686
2013BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanomaHaydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander; Scolyer, Richard; Thompson, John; Wilmott, James; Capper, D; Preusser, Matthias; von Diemling, Andreas Von; Zhang, Yuxiao; Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryBRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma, British Journal of Cancer, vol.108, 4, 2013,pp 924-931
2015Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trialKefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Ashworth, Michelle T; et al, Various; Flaherty, Keith; Gonzalez, Rene; Hamid, Omid; Infante, Jeffrey; Kim, K B; Schuchter, Lynn; Swann, S; Weber, Jeffrey; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineCharacteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase 1/2 clinical trial, Annals of Oncology, vol.26, 2, 2015,pp 415-421
2015Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanomaCarlino, Matteo; Lee, Jenny H J; Long, Georgina; Scolyer, Richard; Tembe, Varsha; Boyd, Suzanah C; Cooper, Adam; et al, Various; Freeman, James; Gray, Elin S; Khattak, Muhammad A; Lo, Johnny; Lomma, Chris; Pereira, Michelle R; Reid, Anna L; Rizos, Helen; Siew, Kelvin; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; Western Clinical School: Westmead Institute for Medical ResCirculating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma, Oncotarget, vol.N/A, N/A, 2015,pp N/A-N/A
2012Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous MelanomaHaydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Murali, Rajmohan; Quinn, Michael; Saw, Robyn; Scolyer, Richard; Shannon, Kerwin; Spillane, Andrew; Stretch, Jonathan; Thompson, John; Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Pathology; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; Central Clinical School: Pathology; Medicine; Northern Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: SurgeryClinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma, Annals of Surgical Oncology, vol.19, 6, 2012,pp 1782-1789
2005Clinical outcome and technical aspects of 263 radial forearm free flaps used in reconstruction of the oral cavity.Andruchow, J; Choy, Ellis; Gao, K; O'Brien, Christopher; Smith, Garett; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Surgery; SurgeryClinical outcome and technical aspects of 263 radial forearm free flaps used in reconstruction of the oral cavity., British Journal Of Oral and Maxillofacial Surgery, vol.43,(3),2005,pp 199-204
2015Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsCarlino, Matteo; Drummond, Martin John; Guminski, Alexander; Kefford, Richard (Rick); Lo, Serigne; Long, Georgina; Lyle, Megan; Menzies, Alexander Maxwel; Scolyer, Richard; Thompson, John; Wilmott, James; Chan, Matthew M K; Western Clinical School: Medicine (Westmead); School of Public Health: Public Health; Medicine Faculty Office; Western Clinical School: Westmead Institute for Medical Res; The George Institute for Global Health; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryClinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors, Cancer, vol.121, 21, 2015,pp 3826-3835